Clinical Trial Search

Primary: The Feasibility of Inpatient Bedside Neurocognitive Testing of Pediatric Patients With Minor Traumatic Brain Injury. — 120 participants

Primary: Change in Vasoreactivity During Exercise at Baseline and 8-week Visits. — 0.031; 0.028 cm s-1 mmHg-1/mmHg CO2

Primary: Mean Difference in Change in Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) Score at Baseline and 6 Weeks. — -0.9; -5.78; 3.52; -7.26 Units on a scale

Primary: Change in Concussive Symptoms on the Post Concussion Symptom Scale — 9 units on a scale

Primary: Change From Baseline on a Composite Measure (Z-score) of Attention, Working Memory, and Executive Functions — 0.26; .01 Change to Z (composite) score

Primary: Longitudinal DTI Changes — 0.000809; 0.000760; 0.000763; 0.000843 voxels

Primary: Post Traumatic Growth — 41.7; 57.8; 40.4; 60.7 Score on a scale

Primary: Time (in Days) That a Patient Reports Symptoms From Their Concussion. — 7.3; 4.5 Days Symptomatic — p=.42

Primary: Determine Average Number of Hits Between Groups — 896.43; 795.40; 144.67; 145.85 number of hits

Primary: Liver Function Testing (Aspartate Transaminase [AST]/Alanine Transaminase [ALT] Ratios) to Screen for Adverse Events. — 1.57; 1.24 AST/ALT ratio

Primary: Pre-season to Post-season DTI Percentage Change — -0.17; -1.27; 0.45; 2.83 percentage of change

Primary: Incidence of RGn550's Adverse Device Effects (ADEs) — 10; 10 Participants

Primary: A Measure Assessing the Sensitivity and Specificity Rate Based on the Nautilus Neurowave Data — 77; 87 percentage of participants

Primary: Performance on Multiple Sleep Latency Test (MSLT) — 6.67; 7.32; 6.73; 7.88 minutes

Primary: Participant Compliance With HeadOn Program — 45; 5 Participants

Primary: Self-report — 7.79; 6.49; 7.61; 7.73 units on a scale

Primary: Number of Participants With Improved Cerebral Perfusion — 8 Participants

Primary: Safety of Higher Dosage of DHA — 0; 1 Participants

Primary: Number of Participants Undergoing Acoustic Reflectance — 410; 410 participants — p=<0.05

Primary: Impact ( Immediate Post-concussion Assessment and Cognitive Testing) Healthy Athlete — 86.33; 84.0; 90.73; 89.1436 score on Immediate post concussion scale — p=0.0003

Primary: Change In SDNN — 43.; 21.87; 19.4 ms

Primary: Participation Assessment With Recombined Tools - Objective 17 (PART-O-17) — 1.30; 1.33 units on a scale — p=0.44

Primary: Summary of Treatment-Emergent Adverse Events — 13; 5; 5; 3 Participants

Primary: Time (in Days) to Recovery — 13; 17 Days

Primary: Percent Change in Trail Making Test Part B Time to Completion — -25.6 percent change in time

Primary: Symptom Management - Post Concussion Symptom Scale — 44; 71; 39; 51 score on a scale

Primary: Post-Intervation Post-concussion Symptom Scores Using RPQ - Intent to Treat — 3.5; 5.1; 4.2; 3.5 units on a scale

Primary: Sleep Quality - Pittsburgh Sleep Quality Index (PSQI) — 1.28; 1.35 score on a scale

Primary: Composite Score of Attention and Executive Functioning From a Neurocognitive Test Battery — 0.18; -0.06 units on a scale

Primary: Memory Test Accuracy on Trained Stimuli — 53.9; 37.6; 48.9; 37.3 Percent correct